Blue Spruce Investments, LP Abbott Laboratories Transaction History

Blue Spruce Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $328 Million - $400 Million	-2,879,361 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $130 Million - $159 Million	-1,126,846 Reduced 28.13%	2,879,361 $405 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $24.3 Million - $26.9 Million	-208,576 Reduced 4.95%	4,006,207 $473 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $322 Million - $380 Million	3,047,969 Added 261.22%	4,214,783 $489 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $127 Million - $150 Million	1,166,814 New	1,166,814 $140 Million

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Blue Spruce Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Blue Spruce Investments, LP with notifications on news.